Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP449531.RAgOHoFMxSiEOGuvN5ULUStD3Ndj5mvz1v-hbUDAqb464130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP449531.RAgOHoFMxSiEOGuvN5ULUStD3Ndj5mvz1v-hbUDAqb464130_assertion type Assertion NP449531.RAgOHoFMxSiEOGuvN5ULUStD3Ndj5mvz1v-hbUDAqb464130_head.
- NP449531.RAgOHoFMxSiEOGuvN5ULUStD3Ndj5mvz1v-hbUDAqb464130_assertion description "[For example, methylation of PTEN and RASSF1A genes occurs mostly in follicular thyroid cancer, and its tumorigenic role may be related to the phosphatidylinositol 3-kinase/Akt signaling pathway, whereas methylation of genes for tissue inhibitor of metalloproteinase-3, SLC5A8, and death-associated protein kinase occurs in papillary thyroid cancer and is related to the BRAF/MAPK kinase/MAPK pathway.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP449531.RAgOHoFMxSiEOGuvN5ULUStD3Ndj5mvz1v-hbUDAqb464130_provenance.
- NP449531.RAgOHoFMxSiEOGuvN5ULUStD3Ndj5mvz1v-hbUDAqb464130_assertion evidence source_evidence_literature NP449531.RAgOHoFMxSiEOGuvN5ULUStD3Ndj5mvz1v-hbUDAqb464130_provenance.
- NP449531.RAgOHoFMxSiEOGuvN5ULUStD3Ndj5mvz1v-hbUDAqb464130_assertion SIO_000772 16946009 NP449531.RAgOHoFMxSiEOGuvN5ULUStD3Ndj5mvz1v-hbUDAqb464130_provenance.
- NP449531.RAgOHoFMxSiEOGuvN5ULUStD3Ndj5mvz1v-hbUDAqb464130_assertion wasDerivedFrom befree-20140225 NP449531.RAgOHoFMxSiEOGuvN5ULUStD3Ndj5mvz1v-hbUDAqb464130_provenance.
- NP449531.RAgOHoFMxSiEOGuvN5ULUStD3Ndj5mvz1v-hbUDAqb464130_assertion wasGeneratedBy ECO_0000203 NP449531.RAgOHoFMxSiEOGuvN5ULUStD3Ndj5mvz1v-hbUDAqb464130_provenance.